Current Drug Targets - Cardiovascular & Hematological Disorders

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, ...read more

  • ISSN (Print): 1568-0061
  • ISSN (Online): 1568-0061
  • Volume: 5
  • Issues: 6, 2005
Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 5, Issue 6, 2005

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression

Pp: 431-432

Author(s): Paul Schoenhagen and Steven E. Nissen

DOI: 10.2174/156800605774962013

Animal Models of Atherosclerosis Progression: Current Concepts

Pp: 433-440

Author(s): A. C. McMahon, L. Kritharides and H. C. Lowe

DOI: 10.2174/156800605774962031

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

Pp: 441-453

Author(s): R. Kleemann and T. Kooistra

DOI: 10.2174/156800605774962077

Cholesterol Absorption Blockade with Ezetimibe

Pp: 455-462

Author(s): Peter P. Toth and Michael H. Davidson

DOI: 10.2174/156800605774962086

Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase

Pp: 463-469

Author(s): Akira Miyazaki, Tomoko Kanome and Takuya Watanabe

DOI: 10.2174/156800605774962040

ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression

Pp: 471-479

Author(s): Sanjay Kaul and Prediman K. Shah

DOI: 10.2174/156800605774962004

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

Pp: 481-488

Author(s): W. A. Van der Steeg, K. El-Harchaoui, J. A. Kuivenhoven and J. J.P. Kastelein

DOI: 10.2174/156800605774961997

A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence

Pp: 489-501

Author(s): R. P. Mason

DOI: 10.2174/156800605774962112

Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis

Pp: 503-512

Author(s): T. J. Allen and K. A. Jandeleit-Dahm

DOI: 10.2174/156800605774962068

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

Pp: 513-525

Author(s): I. Gouni-Berthold and W. Krone

DOI: 10.2174/156800605774962022

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Pp: 527-532

Author(s): A. Zalewski, C. Macphee and J. J. Nelson

DOI: 10.2174/156800605774962103

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

Pp: 533-540

Author(s): Dennis Bruemmer and Ronald E. Law

DOI: 10.2174/156800605774961988

Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis

Pp: 541-548

Author(s): Mustapha Rouis

DOI: 10.2174/156800605774961979

Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction

Pp: 549-556

Author(s): Kishore M. Gadde

DOI: 10.2174/156800605774962095

Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies

Pp: 557-564

Author(s): Todd C. Villines and Allen J. Taylor

DOI: 10.2174/156800605774962059